medigraphic.com
SPANISH

Investigación en Discapacidad

ISSN 2992-779X (Electronic)
ISSN 2007-6452 (Print)
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2025, Number 3

<< Back

Investigación en Discapacidad 2025; 11 (3)

The benefits of treating cataract-related visual disability

Mundo-Fernández EE, Fuentes-Cataño MC, Fabila-Maya MM, Jiménez-Rosas DF, Messina-Baas OM, Quintanar-Haro OD, Urrutia-Breton IP, Zapata-Tarrés MM, Lima-Gómez V
Full text How to cite this article 10.35366/123225

DOI

DOI: 10.35366/123225
URL: https://dx.doi.org/10.35366/123225

Language: Spanish
References: 45
Page: 122-130
PDF size: 781.89 Kb.


Key words:

cataract, cataract surgery, disability, phacoemulsification, rehabilitation.

ABSTRACT

The main objective of cataract surgery is improving vision, and it has other effects over general health such as increasing mobility and making the patient's interpersonal relations easier, which improve quality of life. Cataracts in elder people may coexist with other ocular and extraocular diseases that cause disability, whose approach can be limited by the visual restriction that cataract causes. Since cataracts are a reversible cause of disability, treating it surgically can make easier to deal with other disabilities, so this intervention amplifies the benefit, even when comorbidities could limit visual acuity results. This narrative revision work deals with visual disability in patients with two extraocular and four ocular diseases, and outlines the benefit that could be achieved by reducing it with cataract surgery.


REFERENCES

  1. McCormick I, Butcher R, Evans JR, Mactaggart IZ, Limburg H, Jolley E et al. Effective cataract surgical coverage in adults aged 50 years and older: estimates from population-based surveys in 55 countries. Lancet Glob Health. 2022; 10 (12): e1744-e1753.

  2. Vision Loss Expert Group of the Global Burden of Disease Study; GBD 2019 Blindness and Vision Impairment Collaborators. Global estimates on the number of people blind or visually impaired by cataract: a meta-analysis from 2000 to 2020. Eye (Lond). 2024; 38 (11): 2156-2172.

  3. Blachnio K, Dusinska A, Szymonik J, Juzwiszyn J, Bestecka M, Chabowski M. Quality of life after cataract surgery. J Clin Med. 2024; 13 (17): 5209.

  4. Assi L, Chamseddine F, Ibrahim P, Sabbagh H, Rosman L, Congdon N et al. A global assessment of eye health and quality of life. A systematic review of systematics reviews. JAMA Ophthalmol. 2021; 139: 526-541.

  5. Jansone-Langina Z, Solomatin A, Solomatins M, Krumina G. Quality of life assessment for nuclear, cortical, posterior subcapsular patients before and after cataract surgery. J Optom. 2023; 17 (2): 100489.

  6. Hecht I, Kanclerz P, Tuuminen R. Secondary outcomes of lens and cataract surgery: More than just "best-corrected visual acuity". Prog Retin Eye Res. 2023; 95: 101150.

  7. Afflitto GG, Aiello F, Surico PL, Malek DA, Mori T, Swaminathan SS et al. Cataract and risk of fracture: a systematic review, meta-analysis, and Bayesian network meta-analysis, Ophthalmology. 2025; 132: 921-934.

  8. Boyd M, Kvishinadze G, Kho A, Wilson G, Wilson N. Cataract surgery for falls prevention and improving vision: modelling the health gain, health system cost and cost-effectiveness in high-income country. Inj Prev. 2020; 26: 302-309.

  9. Baig A, Foss A, Sahota O, Sehat K, Ash I. Vision screening in older adults admitted with a fragility hip fracture: A healthcare quality improvement report. Br Ir Orthopt J. 2023; 19: 96-107.

  10. Al-Namaeh M. Common causes of visual impairment in the elderly. Med Hypothesis Discov Eye Innov Ophthalmol. 2022; 10: 191-200.

  11. Zhang JH, Ramke J, Lee CN, Gordon I, Safi S, Lingham G et al. A systematic review of clinical practice guidelines for cataract: evidence to support the development of the WHO package of eye care interventions. Vision (Basel). 2022; 6 (2): 36.

  12. Livingston G, Huntley J, Sommerlad A, Ames D, Ballard C, Banerjee S et al. Dementia prevention, intervention, and care: 2020 report of the Lancet Commission. Lancet. 2020; 396 (10248): 413-446.

  13. Li M, Hamedani AG. Association of visual impairment with neuropsychiatric symptoms of dementia. J Neuroophthalmol. 2025; 45: 131-136.

  14. Lee CS, Gibbons LE, Lee AY, Yanagihara RT, Blazes MS et al. Association between cataract extraction and development of dementia. JAMA Intern Med. 2022; 182: 134-141.

  15. Klauke S, Sondocie C, Fine I. The impact of low vision on social function: the potential importance of lost visual social cues. J Optom. 2022; 16: 3-11.

  16. Joo H, Diaz-Ramirez LG, Chen CL, Sun CQ, Smith AK, Boscardin WJ et al. Cognitive trajectory before and after cataract surgery: A population-based approach. J Am Geriatr Soc. 2025; 73: 1073-1081.

  17. Chen PW, Liu PPS, Lin SM, Wang JH, Huang HK, Loh CH. Cataract and the increased risk of depression in general population: A 16-year nationwide population-based longitudinal study. Sci Rep. 2020; 10: 13421.

  18. Pershing S, Henderson VW, Goldstein MK, Lu Y, Bundorf MK, Rahman M et al. Cataract surgery complexity and surgical complication rates among Medicare beneficiaries with and without dementia. Am J Ophthalmol. 2021; 221: 27-38.

  19. Anggarini DW, Handayaningrum VN, Hening BB. Association between cataract surgery and age-related macular degeneration: a systematic review. JARMHS. 2023; 9 (3): 63-67.

  20. Mehta H. Management of cataract in patients with age-related macular degeneration. J Clin Med. 2021; 10: 2538.

  21. Tang HY, Rosen M, Granstam E. Cataract surgery in neovascular AMD: impact on visual acuity and disease activity. BMC Opthalmol. 2023; 23: 276.

  22. Hossl L, Vaghefi SA, Riemer T, Kabiri P, Bonaventura T, Rübsam A et al. Insights into cataract surgery outcomes in age-related macular degeneration. Perspectives across severity grades under clinical routine conditions. Ophthalmol Retina. 2025; 9: 527-536.

  23. Karesvuo P, Elbaz U, Achiron A, Hecht I, Kaarniranta K, Tuuminen R. Effect of cataract surgery on wet age-related macular degeneration activity. Acta Ophthalmol. 2022; 100: e262-e269.

  24. Klein J, Pierscionek BK, Lauritzen J, Derntl K, Grzybowski A, Zlatkova MB. The effect of cataract on early stage glaucoma detection using spatial and temporal contrast sensitivity tests. PLoS One. 2015; 10: e0128681.

  25. Turalba A, Payal AR, Gonzalez-Gonzalez LA, Cakiner-Egilmez T, Chomsky AS, Vollman DE et al. Cataract surgery outcomes in glaucomatous eyes: results from the Veterans affairs ophthalmic surgery outcomes data project. Am J Ophthalmol. 2015; 160: 693-701.

  26. Skalicky SE, Martin KR, Fenwick E, Crowston JG, Goldberg I, McCluskey P. Cataract and quality of life in patients with glaucoma. Clin Exp Ophthalmol. 2015; 43: 335-341.

  27. Xu X, Sun Q, Ma YY, Zou HD. Vision-related quality of life outcomes of cataract surgery in advanced glaucoma patients. J Glaucoma. 2016; 25: e5-11.

  28. Rao HL, Jonnadula GB, Addepalli UK, Senthil S, Garudadri CS. Effect of cataract extraction on visual field index in glaucoma. J Glaucoma. 2013; 22: 164-168.

  29. Chung HJ, Choi JH, Lee YC, Kim SY. Effect of cataract opacity type and glaucoma severity on visual field index. Optom Vis Sci. 2016; 93: 575-578.

  30. Ivanescu A, Popescu S, Gaita L, Albai O, Braha A, Timar R. Risk factors for cataracts in patients with diabetes mellitus. J Clin Med. 2024; 13: 7005.

  31. Das T, Behera UC, Bhattacharjee H, Gilbert C, Murthy GVS, Rajalakshmi R et al. Spectrum of eye disorders in diabetes (SPEED) in India: Eye care facility based study. Report # 1. Eye disorders in people with type 2 diabetes mellitus. Indian J Ophthalmol. 2020; 68 (Suppl 1): S16-S20.

  32. Wen L, Wang Y, Lin Z, Wang FH, Ding XX, Li D et al. The prevalence and causes of visual impairment in type 2 diabetes mellitus in northeast China. J Ophthalmol. 2020; 2020: 5969816.

  33. Pérez-Peralta L, Rivera-De la Parra D, Graue-Hernández E, Hernández-Jiménez S, Almeda-Valdés P, Velázquez-Jurado H et al. Visual impairment associated with diabetic retinopathy and macular edema: a hospital-based study. Gac Med Mex. 2023; 159: 203-209.

  34. López-Star EM, Allison-Eckert K, Limburg H, Brea-Rodríguez I, Lansingh VC. Evaluación rápida de la ceguera evitable, incluida la retinopatía diabética, en Querétaro, México. Rev Mex Oftalmol. 2018; 92: 84-93.

  35. Madueña-Angulo SE, Beltran-Ontiveros SA, Leal-Leon E, Contreras-Gutierrez JA, Lizárraga-Verdugo E, Gutiérrez-Arzapalo PY et al. National sex- and age-specific burden of blindness and vision impairment by cause in Mexico in 2019: a secondary analysis of the Global Burden of Disease Study 2019. Lancet Reg Health Am. 2023; 24: 100552.

  36. Monestam EI. Long-term results of cataract surgery in type 2 diabetics, a 20 year prospective longitudinal study. Acta Ophthalmol. 2024; 102: 58-67.

  37. Han MM, Song W, Conti T, Conti FF, Greenlee T, Hom G et al. Visual acuity outcomes after cataract extraction with intraocular lens implantation in eyes with diabetic retinopathy. Ophthalmol Retina. 2020; 4: 351-360.

  38. Lee D, Agron E, Keenan T, Lovato J, Ambrosius W, Chew et al. Visual acuity outcomes after cataract surgery in type 2 diabetes: the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Study. Br J Ophthalmol. 2022; 105: 1496-502.

  39. Liu L, Herrinton LJ, Alexeef S, Karter AJ, Amsden LB, Carolan J et al. Visual outcomes after cataract surgery in patients with type 2 diabetes. J Cataract Refract Surg. 2019; 45: 404-413.

  40. Silva LM, Muccioli C, Oliveira FD, Arantes TE, Gonzaga LR, Nakanami CR. Visual impairment from uveitis in a reference hospital of Southeast Brazil: a retrospective review over a twenty years period. Arq Bras Oftalmol. 2013; 76: 366-369.

  41. Levin MH, Pistilli M, Daniel E, Gangaputra SS, Nussenblatt RB, Rosenbaum JT et al. Systemic immunosuppressive therapy for eye diseases cohort study. Incidence of visual improvement in uveitis cases with visual impairment caused by macular edema. Ophthalmology. 2014; 121: 588-595.

  42. Rohl A, Patnaik JL, Lynch AM, Palestine AG. Timing of quiescence and uveitis recurrences after cataract surgery in patients with a history of uveitis. Ophthalmol Ther. 2021; 10: 619-628.

  43. Shekhar M, Chaudhary S, Pai A, Rajesh V, Balakrishnan L, Nagu K et al. Visual outcomes and risk factors of uveitis cataract eyes after phacoemulsification and manual small-incision cataract surgery. J Cataract Refract Surg. 2024; 50: 257-263.

  44. Palson S, Pivodic A, Gronlund M, Lunstrom M, Viberg A, Behndig A et al. Cataract surgery in patients with uveitis: Data from the Swedish National Cataract Register. Acta Ophthalmologica. 2023; 101: 376-383.

  45. Jeviknar K, Pockar S, Umek L, Rothova A, Valentincic NV. Prognostic factors of cataract surgery in patients with uveitis. Int Ophthalmol. 2023; 43: 4605-4612.




Table 1
CC BY-NC-ND

2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Investigación en Discapacidad. 2025;11